Brief: Quantum Genomics announces positive results on phase II of QGC001 arterial hypertension
Sept 29 (Reuters) - Quantum Genomics SA ALQGC.PA :
* Announces positive results for clinical study of phase II
of QGC001 arterial hypertension
* To conduct phase II study in the US on target population
Source text for Eikon: urn:newsml:reuters.com:*:nGNXNHFXAa
Further company coverage: ALQGC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study